Hub : Traits :

Wheeze or whistling in the chest in last year

373 significantly associated models · 70 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 2 102118712 103686111 5 1 4.3e-31 1.3e-24 3.6e-02 96 IL1RL1
2 2 160551143 161166234 1 1 1.4e-07 3.1e-05 2.4e-02 71 PLA2R1
3 2 241941773 243048760 6 2 1.4e-12 5.5e-14 6.9e-01 100 AC114730.7 D2HGDH
4 3 48606701 50921261 15 1 2.0e-13 7.2e-13 1.0e+00 100 RBM6
5 4 122842267 123530993 1 1 5.5e-08 4.1e-07 1.4e-02 76 KIAA1109
6 5 109716442 111105293 1 1 1.7e-08 1.2e-15 7.1e-14 13 TSLP
7 9 4934896 7345304 2 2 2.6e-11 3.8e-29 1.2e-14 52 GLDC KIAA1432
8 9 138920796 140321666 1 1 7.9e-10 2.4e-09 1.0e+00 100 SNHG7
9 11 75678647 77069746 1 1 9.6e-08 2.0e-12 2.0e-06 54 LRRC32
10 11 110776537 112491227 5 1 9.6e-09 1.0e-08 1.0e+00 100 FDXACB1
11 12 66068136 67896003 1 1 2.0e-07 8.4e-06 7.9e-04 43 GRIP1
12 13 99155113 100728229 1 1 1.7e-08 2.5e-07 8.7e-02 89 UBAC2
13 15 66662107 68183665 1 1 1.4e-13 8.8e-15 8.6e-03 88 SMAD3
14 16 10329905 12010444 5 1 3.3e-13 1.8e-18 8.8e-07 69 DEXI
15 16 29972690 31370090 1 1 8.9e-08 2.8e-06 7.7e-01 100 FBRS
16 17 36710513 39048774 16 1 1.9e-14 2.6e-13 5.7e-02 93 RAPGEFL1
17 20 61576647 62912463 7 1 6.3e-10 7.3e-10 1.0e+00 100 ARFRP1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Depressed Affect (Nagel 2018) 1.33 1 1 2.2 0.00 1.0e+00 RBM6
Intelligence (Savage-Jansen 2018) 2.29 1 1 2.2 0.00 1.0e+00 RBM6
Schizophrenia vs Biploar Disorder 2.22 1 0 0.0 0.00 1.0e+00 RBM6
Alzheimer’s Disease (in mother) 1.82 1 0 0.0 0.00 1.0e+00 FBRS
Alzheimer’s Disease (including proxy) 1.70 1 0 0.0 0.00 1.0e+00 FBRS
Crohns Disease (2017) 7.04 6 4 8.9 0.50 3.2e-01 ARFRP1 KIAA1109 LRRC32 RAPGEFL1 RBM6 SMAD3
Irritable Bowel Disease (IBD) 8.91 6 6 13.3 0.43 4.0e-01 ARFRP1 KIAA1109 LRRC32 RAPGEFL1 RBM6 SMAD3
Ulcerative Colitis (UC) 6.55 6 4 8.9 0.29 5.7e-01 ARFRP1 KIAA1109 LRRC32 RAPGEFL1 RBM6 SMAD3
Verbal and Numeric Reasoning (VNR) 1.93 1 1 2.2 0.00 1.0e+00 RBM6
Prostate Cancer 2.71 1 1 2.2 0.00 1.0e+00 ARFRP1
Age at First Birth 2.80 1 1 2.2 0.00 1.0e+00 RBM6
Coronary Artery Disease (CAD) 2.50 1 0 0.0 0.00 1.0e+00 RBM6
Crohns Disease (2012) 6.92 5 3 6.7 0.48 4.2e-01 ARFRP1 LRRC32 RAPGEFL1 RBM6 SMAD3
HDL Cholesterol 2.72 1 1 2.2 0.00 1.0e+00 RAPGEFL1
Primary Biliary Cirrhosis 3.45 1 1 2.2 0.00 1.0e+00 RAPGEFL1
Triglycerides 1.47 1 0 0.0 0.00 1.0e+00 FBRS
Ulcerative Colitis 6.84 4 3 6.7 0.21 7.9e-01 ARFRP1 KIAA1109 RAPGEFL1 RBM6
Blood Eosinophil Count 29.43 14 12 26.7 0.89 2.5e-05 AC114730.7 D2HGDH DEXI FBRS GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 PLA2R1 RBM6 SMAD3 TSLP UBAC2
Blood Platelet Count 0.72 2 1 2.2 0.00 1.0e+00 ARFRP1 PLA2R1
Blood Red Count 0.81 2 2 4.4 0.00 1.0e+00 ARFRP1 FBRS
Blood White Count 13.56 7 5 11.1 0.53 2.2e-01 ARFRP1 DEXI FBRS IL1RL1 PLA2R1 RAPGEFL1 RBM6
Heel T-Score 1.17 3 2 4.4 0.00 1.0e+00 FBRS RBM6 SNHG7
BMI 3.43 4 2 4.4 1.00 2.4e-03 ARFRP1 FBRS PLA2R1 RBM6
Height 0.68 4 2 4.4 -0.98 1.8e-02 ARFRP1 FDXACB1 GRIP1 SNHG7
Waist Hip Ratio (WHR) 1.06 2 0 0.0 0.00 1.0e+00 DEXI SMAD3
Systolic Blood Pressure 1.02 1 1 2.2 0.00 1.0e+00 FDXACB1
Smoking Status 1.77 1 0 0.0 0.00 1.0e+00 ARFRP1
Allergy or Eczema 31.26 13 11 24.4 0.95 7.0e-07 AC114730.7 ARFRP1 D2HGDH DEXI FDXACB1 GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 SMAD3 TSLP
Cardiovascular Disease 2.01 2 2 4.4 0.00 1.0e+00 FBRS FDXACB1
Hypothyroidism (self reported) 1.18 1 0 0.0 0.00 1.0e+00 KIAA1109
Respiratory disease 38.75 15 13 28.9 0.96 7.4e-09 AC114730.7 ARFRP1 D2HGDH DEXI FDXACB1 GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 RBM6 SMAD3 TSLP UBAC2
Type 2 Diabetes (T2D) (2018) 1.90 1 0 0.0 0.00 1.0e+00 RBM6
Lung FEV1/FVC ratio 3.19 8 3 6.7 -1.00 1.3e-07 AC114730.7 D2HGDH DEXI GLDC IL1RL1 KIAA1432 RAPGEFL1 SMAD3
Lung FVC 2.56 3 1 2.2 0.00 1.0e+00 ARFRP1 FBRS RBM6
Chronotype (morning person) 1.35 1 0 0.0 0.00 1.0e+00 KIAA1109
Hair Pigment 0.15 1 1 2.2 0.00 1.0e+00 KIAA1432
Hand grip strength (left) 0.94 1 0 0.0 0.00 1.0e+00 FBRS
Number of treatments/medications taken 3.73 1 1 2.2 0.00 1.0e+00 RBM6
Medication: Co-codamol 2.76 1 0 0.0 0.00 1.0e+00 RBM6
Impedance of leg (right) 1.52 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Leg fat-free mass (left) 1.78 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Trunk fat percentage 2.79 4 3 6.7 1.00 2.7e-03 ARFRP1 FBRS PLA2R1 RBM6
Current tobacco smoking 2.52 1 0 0.0 0.00 1.0e+00 ARFRP1
Fed-up feelings 1.29 1 1 2.2 0.00 1.0e+00 RBM6
Taking other prescription medications 6.81 4 2 4.4 0.93 6.8e-02 D2HGDH IL1RL1 RAPGEFL1 RBM6
Age when periods started (menarche) 1.24 1 0 0.0 0.00 1.0e+00 RBM6
Heel bone mineral density (BMD) T-score, automated (left) 1.02 1 0 0.0 0.00 1.0e+00 RBM6
High blood pressure 1.53 2 1 2.2 0.00 1.0e+00 FBRS FDXACB1
Hayfever, allergic rhinitis or eczema 27.69 13 10 22.2 0.95 1.1e-06 AC114730.7 ARFRP1 D2HGDH DEXI FDXACB1 GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 SMAD3 TSLP
Sitting height 0.70 2 1 2.2 0.00 1.0e+00 FDXACB1 SNHG7
Body mass index (BMI) 3.99 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Impedance of leg (left) 1.51 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Leg predicted mass (left) 1.78 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Trunk fat mass 3.03 4 3 6.7 1.00 9.6e-04 ARFRP1 FBRS PLA2R1 RBM6
Waist circumference 3.45 4 2 4.4 0.99 7.0e-03 ARFRP1 FBRS PLA2R1 RBM6
Number of incorrect matches in round 1.66 1 1 2.2 0.00 1.0e+00 FBRS
Past tobacco smoking 1.38 1 0 0.0 0.00 1.0e+00 GLDC
Frequency of tenseness / restlessness in last 2 weeks 1.76 1 0 0.0 0.00 1.0e+00 RBM6
Forced vital capacity (FVC) 1.78 1 1 2.2 0.00 1.0e+00 ARFRP1
Qualifications: None of the above 1.73 1 1 2.2 0.00 1.0e+00 RBM6
Financial difficulties in last 2 years 1.89 1 0 0.0 0.00 1.0e+00 FBRS
Allergy 37.71 14 13 28.9 -0.97 1.3e-08 AC114730.7 ARFRP1 D2HGDH DEXI FDXACB1 GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 SMAD3 TSLP UBAC2
Diabetes (self-reported) 1.58 1 0 0.0 0.00 1.0e+00 RBM6
Hayfever/allergic rhinitis (self-reported) 17.22 11 8 17.8 0.98 2.7e-07 AC114730.7 D2HGDH DEXI GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 SMAD3 TSLP
Fluid intelligence score 2.22 1 1 2.2 0.00 1.0e+00 RBM6
Illnesses of siblings 1.47 1 0 0.0 0.00 1.0e+00 FBRS
Neuroticism score 0.87 1 0 0.0 0.00 1.0e+00 RBM6
Weight 3.02 4 2 4.4 1.00 6.3e-04 ARFRP1 FBRS GRIP1 RBM6
Impedance of arm (right) 2.58 4 3 6.7 0.17 8.3e-01 FBRS LRRC32 RAPGEFL1 RBM6
Arm fat percentage (right) 3.09 3 2 4.4 0.00 1.0e+00 ARFRP1 FBRS RBM6
Trunk fat-free mass 1.27 3 2 4.4 0.00 1.0e+00 FBRS RBM6 SNHG7
Hip circumference 3.10 3 3 6.7 0.00 1.0e+00 ARFRP1 FBRS RBM6
Alcohol intake versus 10 years previously 2.10 1 1 2.2 0.00 1.0e+00 RBM6
Forced expiratory volume in 1-second (FEV1) 1.92 2 1 2.2 0.00 1.0e+00 ARFRP1 RBM6
Qualifications: A levels/AS levels or equivalent 2.75 1 1 2.2 0.00 1.0e+00 RBM6
Mouth/teeth dental problems: Dentures 2.19 1 1 2.2 0.00 1.0e+00 RBM6
Asthma 37.91 15 12 26.7 0.96 7.1e-09 AC114730.7 ARFRP1 D2HGDH DEXI FDXACB1 GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 RBM6 SMAD3 TSLP UBAC2
Forced expiratory volume in 1-second (FEV1), Best measure 2.22 4 1 2.2 -0.98 1.5e-02 ARFRP1 FBRS PLA2R1 RBM6
Impedance of arm (left) 2.46 4 2 4.4 0.14 8.6e-01 FBRS LRRC32 RAPGEFL1 RBM6
Arm fat mass (right) 3.58 3 2 4.4 0.00 1.0e+00 ARFRP1 FBRS RBM6
Trunk predicted mass 1.27 3 2 4.4 0.00 1.0e+00 FBRS RBM6 SNHG7
Standing height 0.47 1 1 2.2 0.00 1.0e+00 SNHG7
Tense / 'highly strung' 1.34 1 0 0.0 0.00 1.0e+00 FBRS
Ever highly irritable/argumentative for 2 days 2.09 1 1 2.2 0.00 1.0e+00 RBM6
Qualifications: O levels/GCSEs or equivalent 0.84 1 0 0.0 0.00 1.0e+00 RBM6
Medication for cholesterol, blood pressure or diabetes 1.64 1 0 0.0 0.00 1.0e+00 FDXACB1
Hypothyroidism/myxoedema (self-reported) 1.28 1 0 0.0 0.00 1.0e+00 KIAA1109
Medication: Ventolin 100micrograms inhaler 16.50 9 6 13.3 1.00 4.7e-09 AC114730.7 D2HGDH GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 SMAD3
Birth weight 1.96 2 1 2.2 0.00 1.0e+00 FDXACB1 PLA2R1
Chronic bronchitis/emphysema (mother) 3.17 1 0 0.0 0.00 1.0e+00 RBM6
High blood pressure (siblings) 1.24 1 0 0.0 0.00 1.0e+00 FBRS
Forced vital capacity (FVC), Best measure 1.81 3 1 2.2 0.00 1.0e+00 ARFRP1 FBRS RBM6
Body fat percentage 3.26 4 3 6.7 1.00 1.2e-03 ARFRP1 FBRS PLA2R1 RBM6
Leg fat percentage (right) 3.78 4 3 6.7 1.00 9.8e-04 ARFRP1 FBRS PLA2R1 RBM6
Arm fat-free mass (right) 2.11 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Exposure to tobacco smoke outside home 1.79 1 0 0.0 0.00 1.0e+00 RBM6
Comparative body size at age 10 1.12 1 0 0.0 0.00 1.0e+00 FBRS
Age at first live birth 3.09 1 1 2.2 0.00 1.0e+00 RBM6
Shortness of breath walking on level ground 2.93 1 0 0.0 0.00 1.0e+00 LRRC32
Qualifications: College or University degree 3.51 3 1 2.2 0.00 1.0e+00 ARFRP1 FBRS RBM6
Emphysema/chronic bronchitis 3.72 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Medication: Blood pressure 1.30 1 0 0.0 0.00 1.0e+00 FDXACB1
Medication: Seretide 50 evohaler 8.91 4 1 2.2 0.99 1.0e-02 AC114730.7 D2HGDH IL1RL1 SMAD3
Whole body fat mass 3.58 4 3 6.7 1.00 2.9e-04 ARFRP1 FBRS PLA2R1 RBM6
Leg fat mass (right) 3.97 4 3 6.7 1.00 5.1e-04 ARFRP1 FBRS PLA2R1 RBM6
Arm predicted mass (right) 2.22 4 2 4.4 0.60 4.0e-01 FBRS GRIP1 RBM6 SNHG7
Pulse rate, automated reading 1.21 2 0 0.0 0.00 1.0e+00 FDXACB1 RBM6
Alcohol intake frequency. 1.80 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Overall health rating 2.94 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Chest pain or discomfort 3.88 3 0 0.0 0.00 1.0e+00 IL1RL1 RAPGEFL1 RBM6
Age at last live birth 2.90 1 1 2.2 0.00 1.0e+00 RBM6
Leg pain on walking 1.86 1 0 0.0 0.00 1.0e+00 RBM6
Qualifications: NVQ or HND or HNC or equivalent 1.76 1 0 0.0 0.00 1.0e+00 RBM6
Knee pain experienced in last month 2.56 2 0 0.0 0.00 1.0e+00 FBRS RBM6
Hypertension (Self-reported) 1.53 2 1 2.2 0.00 1.0e+00 FBRS FDXACB1
Whole body fat-free mass 1.57 3 2 4.4 0.00 1.0e+00 FBRS RBM6 SNHG7
Leg fat-free mass (right) 1.62 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Arm fat percentage (left) 3.07 3 2 4.4 0.00 1.0e+00 ARFRP1 FBRS RBM6
Mood swings 1.39 1 1 2.2 0.00 1.0e+00 RBM6
Diabetes diagnosed by doctor 1.79 1 0 0.0 0.00 1.0e+00 RBM6
Qualifications: nursing, teaching 1.02 1 0 0.0 0.00 1.0e+00 RBM6
Mouth/teeth dental problems: Mouth ulcers 1.84 1 0 0.0 0.00 1.0e+00 RAPGEFL1
Asthma (self-reported) 37.61 15 12 26.7 0.96 9.8e-09 AC114730.7 ARFRP1 D2HGDH DEXI FDXACB1 GLDC IL1RL1 KIAA1109 KIAA1432 LRRC32 RAPGEFL1 RBM6 SMAD3 TSLP UBAC2
Smoking status: Current 2.23 1 0 0.0 0.00 1.0e+00 ARFRP1
Forced expiratory volume in 1-second (FEV1), predicted percentage 4.20 4 2 4.4 -0.96 3.5e-02 ARFRP1 FBRS PLA2R1 RAPGEFL1
Whole body water mass 1.60 3 2 4.4 0.00 1.0e+00 FBRS RBM6 SNHG7
Leg predicted mass (right) 1.60 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Arm fat mass (left) 3.62 3 2 4.4 0.00 1.0e+00 ARFRP1 FBRS RBM6
Number of self-reported non-cancer illnesses 6.28 5 0 0.0 0.98 2.8e-03 ARFRP1 D2HGDH IL1RL1 LRRC32 RAPGEFL1
Miserableness 2.29 2 1 2.2 0.00 1.0e+00 RAPGEFL1 RBM6
Medication: Blood pressure 1.87 2 0 0.0 0.00 1.0e+00 FBRS FDXACB1
Basal metabolic rate 1.93 2 2 4.4 0.00 1.0e+00 FBRS RBM6
Leg fat percentage (left) 3.91 4 3 6.7 1.00 2.0e-03 ARFRP1 FBRS PLA2R1 RBM6
Arm fat-free mass (left) 2.27 3 2 4.4 0.00 1.0e+00 FBRS GRIP1 RBM6
Number of operations (self-reported) 1.85 2 0 0.0 0.00 1.0e+00 DEXI RBM6
Average weekly beer plus cider intake 1.73 1 1 2.2 0.00 1.0e+00 RBM6
Diastolic blood pressure, automated reading 1.94 3 0 0.0 0.00 1.0e+00 ARFRP1 FBRS RBM6
Vascular/heart problems diagnosed by doctor 1.68 2 1 2.2 0.00 1.0e+00 FBRS FDXACB1
Cholesterol lowering medication 1.31 1 0 0.0 0.00 1.0e+00 FBRS
Pain experienced in last month 2.23 2 0 0.0 0.00 1.0e+00 FBRS RBM6
Heart disease (siblings) 1.69 1 0 0.0 0.00 1.0e+00 SMAD3
Impedance of whole body 2.06 3 2 4.4 0.00 1.0e+00 FBRS LRRC32 RBM6
Leg fat mass (left) 4.02 4 3 6.7 1.00 6.9e-04 ARFRP1 FBRS PLA2R1 RBM6
Arm predicted mass (left) 2.30 3 2 4.4 0.00 1.0e+00 FBRS GRIP1 RBM6

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 5 0.143 1.8
GTEx Adipose Visceral Omentum 4 0.196 1.9
GTEx Adrenal Gland 3 0.206 1.7
GTEx Artery Aorta 4 0.134 1.9
GTEx Artery Coronary 1 0.085 1.8
GTEx Artery Tibial 8 0.213 1.9
GTEx Brain Caudate basal ganglia 2 0.217 1.7
GTEx Brain Cerebellar Hemisphere 5 0.336 1.9
GTEx Brain Cerebellum 6 0.303 1.9
GTEx Brain Cortex 3 0.290 1.9
GTEx Brain Frontal Cortex BA9 4 0.433 2.0
GTEx Brain Hippocampus 0 0.000 1.6
GTEx Brain Hypothalamus 1 0.169 1.8
GTEx Brain Nucleus accumbens basal ganglia 3 0.347 1.8
GTEx Brain Putamen basal ganglia 3 0.481 1.9
GTEx Breast Mammary Tissue 8 0.405 1.9
GTEx Breast Mammary Tissue (Male) 3 0.251 1.8
GTEx Breast Mammary Tissue (Female) 4 0.243 1.9
GTEx Cells EBV-transformed lymphocytes 2 0.141 1.8
GTEx Cells Transformed fibroblasts 12 0.286 1.9
GTEx Colon Sigmoid 2 0.137 1.9
GTEx Colon Transverse 8 0.388 1.9
GTEx Esophagus Gastroesophageal Junction 3 0.208 1.8
GTEx Esophagus Mucosa 9 0.271 1.8
GTEx Esophagus Muscularis 6 0.186 1.9
GTEx Heart Atrial Appendage 4 0.253 1.8
GTEx Heart Left Ventricle 2 0.131 1.8
GTEx Liver 2 0.279 1.6
GTEx Lung 5 0.174 1.8
GTEx Muscle Skeletal 7 0.242 1.7
GTEx Nerve Tibial 5 0.116 1.8
GTEx Ovary 1 0.110 1.8
GTEx Pancreas 4 0.245 1.8
GTEx Pituitary 3 0.269 1.8
GTEx Prostate 2 0.240 1.9
GTEx Skin Not Sun Exposed Suprapubic 7 0.285 1.9
GTEx Skin Sun Exposed Lower leg 9 0.247 1.9
GTEx Small Intestine Terminal Ileum 1 0.217 1.9
GTEx Spleen 8 0.567 1.9
GTEx Stomach 3 0.206 1.8
GTEx Testis 9 0.285 1.8
GTEx Thyroid 13 0.325 1.9
GTEx Uterus 2 0.353 1.9
GTEx Vagina 1 0.157 1.7
GTEx Whole Blood 7 0.351 1.8
METSIM Adipose 7 0.152 1.7
NTR Blood 5 0.208 1.8
ROSMAP Brain Pre-frontal Cortex 8 0.182 1.8
YFS Blood 7 0.152 1.8
CommonMind Brain Pre-frontal Cortex 12 0.223 1.7
The Cancer Genome Atlas Bladder Urothelial Carcinoma 4 0.242 1.8
The Cancer Genome Atlas Breast Invasive Carcinoma 12 0.272 1.7
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 3 0.273 1.7
The Cancer Genome Atlas Colon Adenocarcinoma 6 0.291 1.7
The Cancer Genome Atlas Esophageal Carcinoma 1 0.146 1.7
The Cancer Genome Atlas Glioblastoma Multiforme 2 0.196 1.7
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 6 0.220 1.8
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 13 0.317 1.8
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 4 0.195 1.8
The Cancer Genome Atlas Brain Lower Grade Glioma 10 0.232 1.7
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 3 0.271 1.7
The Cancer Genome Atlas Lung Adenocarcinoma 8 0.272 1.8
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 7 0.279 1.8
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 3 0.188 1.7
The Cancer Genome Atlas Pancreatic Adenocarcinoma 7 0.421 1.8
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 3 0.226 1.6
The Cancer Genome Atlas Prostate Adenocarcinoma 12 0.260 1.7
The Cancer Genome Atlas Rectum Adenocarcinoma 2 0.289 1.6
The Cancer Genome Atlas Soft Tissue Sarcoma 1 0.094 1.6
The Cancer Genome Atlas Skin Cutaneous Melanoma 1 0.187 1.8
The Cancer Genome Atlas Stomach Adenocarcinoma 6 0.356 1.9
The Cancer Genome Atlas Testicular Germ Cell Tumors 4 0.313 1.8
The Cancer Genome Atlas Thyroid Carcinoma 11 0.213 1.8
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 1 0.197 1.8